Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.
Jason R. Gotlib
Advertisement
Articles by Jason R. Gotlib
Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.
Advertisement
Latest Updated Articles
Jason R. Gotlib Discusses MPN Research at StanfordPublished: December 22nd 2015 | Updated:
Jason R. Gotlib on JAK Inhibitors for the Treatment of MyelofibrosisPublished: March 23rd 2016 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer
2
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
3
Trodelvy Plus Keytruda Upholds Quality of Life in TNBC
4
A Breast Cancer Survivor's Delightful Dilemma
5
